Amanda Soares Hirata (Amanda S Hirata)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Top Venues

Beilstein journal of organic chemistry

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Manoel Trindade Rodrigues, Aline Silva Barroso de Oliveira, Ralph C Gomes, Amanda Soares Hirata, Lucas A Zeoly, Hugo Santos, João Arantes, Catarina Sofia Mateus Reis-Silva, João Agostinho Machado-Neto, Leticia Veras Costa-Lotufo, Fernando Coelho
Bismuth(III) triflate: an economical and environmentally friendly catalyst for the Nazarov reaction. Beilstein journal of organic chemistry 20 (2024)
Manoel Trindade Rodrigues, Aline Silva Barroso de Oliveira, Ralph C Gomes, Amanda Soares Hirata, Lucas A Zeoly, Hugo Santos, João Arantes, Catarina Sofia Mateus Reis-Silva, João Agostinho Machado-Neto, Leticia Veras Costa-Lotufo, Fernando Coelho
Bismuth(III) triflate: an economical and environmentally friendly catalyst for the Nazarov reaction. Beilstein journal of organic chemistry 20 (2024)
Amanda Soares Hirata, James J La Clair, Paula C Jimenez, Leticia Veras Costa-Lotufo, William Fenical
Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma. Marine drugs 20 (5) (2022)
Rodrigo Dos A Miguel, Amanda Soares Hirata, Paula C Jimenez, Luciana B Lopes, Leticia Veras Costa-Lotufo
Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs. Pharmaceutics 14 (8) (2022)
Amanda Soares Hirata, Paula Rezende-Teixeira, João Agostinho Machado-Neto, Paula Christine Jimenez, James J La Clair, William Fenical, Leticia Veras Costa-Lotufo
Seriniquinones as Therapeutic Leads for Treatment of BRAF and NRAS Mutant Melanomas. Molecules (Basel, Switzerland) 26 (23) (2021)
Alexsandra Conceição Apolinário, Amanda Soares Hirata, Rodrigo Dos A Miguel, Leticia Veras Costa-Lotufo, Adalberto Pessoa, James J La Clair, William Fenical, Luciana Biagini Lopes
Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine (London, England) 15 (26) (2020)